These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 16404227

  • 1. Early dynamic 201Tl SPECT in the evaluation of brain tumours.
    Sugo N, Yokota K, Kondo K, Harada N, Aoki Y, Miyazaki C, Nemoto M, Kano T, Ohishi H, Seiki Y.
    Nucl Med Commun; 2006 Feb; 27(2):143-9. PubMed ID: 16404227
    [Abstract] [Full Text] [Related]

  • 2. Initial application of respiratory-gated 201Tl SPECT in pulmonary malignant tumours.
    Kawakami Y, Suga K, Yamashita T, Iwanaga H, Zaki M, Matsunaga N.
    Nucl Med Commun; 2005 Apr; 26(4):303-13. PubMed ID: 15753789
    [Abstract] [Full Text] [Related]

  • 3. Technetium-99m(V)-DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade.
    Hirano T, Otake H, Kazama K, Wakabayashi K, Zama A, Shibasaki T, Tamura M, Endo K.
    J Nucl Med; 1997 Nov; 38(11):1741-9. PubMed ID: 9374344
    [Abstract] [Full Text] [Related]

  • 4. Behaviors of cost functions in image registration between 201Tl brain tumor single-photon emission computed tomography and magnetic resonance images.
    Soma T, Takaki A, Teraoka S, Ishikawa Y, Murase K, Koizumi K.
    Ann Nucl Med; 2008 Nov; 22(9):825-32. PubMed ID: 19039563
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.
    Sasaki M, Kuwabara Y, Yoshida T, Nakagawa M, Fukumura T, Mihara F, Morioka T, Fukui M, Masuda K.
    Eur J Nucl Med; 1998 Sep; 25(9):1261-9. PubMed ID: 9724375
    [Abstract] [Full Text] [Related]

  • 7. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
    Sugawara Y, Kikuchi T, Kajihara M, Semba T, Ochi T, Fujii T, Mochizuki T, Sakayama K, Nakata S.
    Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of 99Tcm-MIBI with 201Tl chloride SPET in patients with malignant brain tumours.
    Nishiyama Y, Yamamoto Y, Fukunaga K, Satoh K, Kunishio K, Ohkawa M.
    Nucl Med Commun; 2001 Jun; 22(6):631-9. PubMed ID: 11403173
    [Abstract] [Full Text] [Related]

  • 12. Dynamic 99Tcm-ECD SPET correlates well with 201Tl indices in brain tumours.
    Miyazawa N, Koizumi K, Arbab AS, Tohyama K.
    Nucl Med Commun; 1999 Nov; 20(11):1023-9. PubMed ID: 10572912
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
    Gómez-Río M, Rodríguez-Fernández A, Ramos-Font C, López-Ramírez E, Llamas-Elvira JM.
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):966-75. PubMed ID: 18172642
    [Abstract] [Full Text] [Related]

  • 14. Differential diagnosis in patients with ring-like thallium-201 uptake in brain SPECT.
    Kinuya K, Ohashi M, Itoh S, Yamamoto K, Sakai S, Kakuda K, Nobata K, Kato N, Terahara S, Taki S.
    Ann Nucl Med; 2002 Sep; 16(6):417-21. PubMed ID: 12416581
    [Abstract] [Full Text] [Related]

  • 15. Thallium-201 SPECT in prognostic assessment of malignant gliomas treated with postoperative radiotherapy.
    Semba T, Sugawara Y, Ochi T, Fujii T, Mochizuki T, Ohnishi T.
    Ann Nucl Med; 2006 May; 20(4):287-94. PubMed ID: 16856572
    [Abstract] [Full Text] [Related]

  • 16. Postoperative residual tumour imaged by contrast-enhanced computed tomography and 201Tl single photon emission tomography: can they predict progression-free survival in high-grade gliomas?
    Datta NR, Pasricha R, Gambhir S, Phadke RV, Prasad SN.
    Clin Oncol (R Coll Radiol); 2004 Oct; 16(7):494-500. PubMed ID: 15490813
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of triple-phase thallium-201 SPECT in non-small-cell lung cancer (NSCLC): association with proliferative activity.
    Fujita S, Nagamachi S, Wakamatsu H, Nishii R, Futami S, Tamura S, Matsuzaki Y, Onizuka T, Hatakeyama K, Asada Y.
    Ann Nucl Med; 2008 Dec; 22(10):833-9. PubMed ID: 19142701
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of malignancy and viability of brain tumors by 201Tl SPECT: the correlation between 201Tl SPECT and pathology, clinical progress and the intensity of enhancement on CT images].
    Ohnishi H, Koizumi K, Uchiyama G, Yamaguchi M, Okada J, Ogata H, Toyama K, Monzawa S, Oba H, Araki T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Dec 25; 54(14):1388-98. PubMed ID: 7596768
    [Abstract] [Full Text] [Related]

  • 19. [The use of SPECT with 201Tl in the evaluation of brain tumors].
    Prat-Acín R, Díaz-Vicente J, Banzo J, Villagrasa J, Prats E, Delgado M, Abós MD.
    Rev Neurol; 1996 Aug 25; 24(132):909-13. PubMed ID: 8755351
    [Abstract] [Full Text] [Related]

  • 20. Sequential scintigraphic strategy for the differentiation of brain tumours.
    Matheja P, Rickert C, Weckesser M, Palkovic S, Löttgen J, Riemann B, Kopka K, Kuwert T, Wassmann H, Paulus W, Schober O.
    Eur J Nucl Med; 2000 May 25; 27(5):550-8. PubMed ID: 10853811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.